Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Calliditas Therapeutics AB (publ)
  6. News
  7. Summary
    CALTX   SE0010441584

CALLIDITAS THERAPEUTICS AB (PUBL)

(CALTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Flat in Wednesday Morning Trading

06/16/2021 | 11:21am EDT


© MT Newswires 2021
All news about CALLIDITAS THERAPEUTICS AB (PUBL)
07/23CALLIDITAS THERAPEUTICS : and STADA partner to register and commercialize specia..
PU
07/21CALLIDITAS THERAPEUTICS : Grants Germany's STADA Arzneimittel License to Kidney ..
MT
07/21CALLIDITAS THERAPEUTICS : STADA Form $115 Million Drug Distribution Deal
MT
07/21Calliditas Therapeutics and STADA Arzneimittel AG Partners to Register and Co..
CI
07/21CALLIDITAS THERAPEUTICS : and STADA partner to register and commercialize specia..
AQ
07/19CALLIDITAS THERAPEUTICS : secures $75 million term loan facility (Form 6-K)
PU
07/15European ADRs Move Lower in Thursday Trading
MT
07/15CALLIDITAS THERAPEUTICS : Secures $75 Million Debt Facility from Kreos Capital
MT
07/15CALLIDITAS THERAPEUTICS : Signs $75 Million Loan Deal
MT
07/15CALLIDITAS THERAPEUTICS : secures $75 million term loan facility
AQ
More news
Financials
Sales 2021 10,4 M 1,21 M 1,21 M
Net income 2021 -603 M -69,9 M -69,9 M
Net cash 2021 212 M 24,6 M 24,6 M
P/E ratio 2021 -11,2x
Yield 2021 -
Capitalization 6 482 M 751 M 751 M
EV / Sales 2021 600x
EV / Sales 2022 10,6x
Nbr of Employees 46
Free-Float 80,1%
Chart CALLIDITAS THERAPEUTICS AB (PUBL)
Duration : Period :
Calliditas Therapeutics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CALLIDITAS THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 129,80 SEK
Average target price 240,00 SEK
Spread / Average Target 84,9%
EPS Revisions
Managers and Directors
Renée Julie Elisabet Aguiar-Lucander Chief Executive Officer
Fredrik Johansson Chief Financial Officer
Elmar J. Schnee Chairman
Johan Erik Häggblad Chief Scientific Officer
Richard Philipson Chief Medical Officer